Even Your Doctor Has Nothing on AI
How are you holding up? Hope life’s been life-ing softly and not too much drama.
Anywayyy... you know I’ve got you with the gist that actually matters, so let’s get right into it.
MAI-Dx0 Might Be Smarter Than Your Doctor👀
Microsoft just announced that its AI is now diagnosing complicated medical cases better than actual doctors. Yes, you heard right. BETTER.
Their AI tool MAI-Dx0 (cute name) went head-to-head with experienced doctors on some of the hardest cases from the New England Journal of Medicine... and blew them out of the water.
According to the report, MAI-Dx0 can correctly diagnose up to 85% of the New England Journal of Medicine's case proceedings, which is more than four times higher than a group of experienced physicians.
This AI isn't just some random tool. It was built with power from OpenAI, the same people behind ChatGPT. Microsoft and OpenAI have been in this deep tech-marriage since 2019, and Microsoft has already spent nearly $14 billion on them. Since then, Microsoft’s stock has skyrocketed by 263%. Investors are literally eating well.
Now, with all the medical data they’re crunching, Microsoft says they’re already seeing 50 million health questions daily through Bing and Copilot. And they’re not joking around. Their goal is to give the most accurate, cheapest health advice ever. Like, imagine replacing that ₦50k doctor consultation with a chatbot. 😳
The future of healthcare might just be... a computer. But for now, don’t fire your doctor. Just yet
Elon’s Grip on the EV Throne Is Slipping
Tesla dropped their Q2 report, and it’s a mixed bag. So they delivered 384,122 cars in Q2, basically how many they sold. That’s a 13.5% drop compared to last year, and even worse than the 13% drop in Q1. In fact, this is the worst sales drop Tesla has ever reported.
But even though the numbers were bad, they weren’t as bad as expected. Most analysts were bracing for the worst. Some even predicted it would fall to 356k deliveries. So the fact that it was over 384k gave investors a little relief.
Still, the future isn’t looking too bright. The next few quarters are going to be tough, and unless Tesla pulls off a miracle, they might see a second year in a row of declining growth, which is wild considering Elon Musk used to brag about 50% yearly growth targets. That dream? Pretty much dead now.
Still, don’t get too excited. Tesla’s bigger picture is cracking. Their CEO used to brag about growing deliveries by 50% every year, lol, not anymore. This could be the second year in a row of negative growth. Imagine!
Meanwhile, BYD from China is on fire...yeah! They’ve already sold 300,000 more EVs than Tesla this year, and they’re not slowing down, so if Tesla doesn’t pull off some serious magic, Elon is about to lose his EV throne, and the headline will write itself.
So yeah, Tesla dodged a bullet this quarter, but they’re far from out of the woods. All eyes are now on their Q2 earnings report, especially to see if they’ll finally say something concrete about the long-awaited low-cost Tesla model everyone’s been waiting for.
Paramount Paid $16M to Make It Go Away…
So, Paramount Global, you know, the people that own CBS, just agreed to pay $16 million to settle a lawsuit Trump brought against them.
Now, here is the backstory. Back in 2020, during the elections, 60 Minutes (that big American news show) did an interview with Kamala Harris, and apparently, they aired two different versions of it. Trump said they were trying to twist the narrative and interfere with the election.
Now, our guy Trump did not come to play, he sued for $20 billion. But at the end of the day, Paramount said, “Let’s settle this thing fast, fast,” and offered $16 million.
But the interesting fact is that Trump won’t even get the money himself. The bulk of it is going to legal fees, and the rest is headed to his future presidential library. So technically, it’s not hush money, but it’s giving “let’s just move on, abeg.”
Paramount didn’t even apologize; they simply said they’ll start releasing full transcripts of interviews with presidential candidates going forward. That’s their own peace offering.
Some people are whispering that this settlement isn’t just about the lawsuit. Paramount is trying to merge with Skydance Media (yes, like movie-level big), and they know federal regulators are watching.
So this move is likely them trying to clean up their mess and avoid bad press before the merger is reviewed.
AbbVie’s Billion-Dollar Deal
AbbVie, the big pharma giant, just spent a wild $2.1 billion to buy a young biotech company called Capstan Therapeutics.
The drama is loud because AbbVie’s cash cow, Humira, the arthritis blockbuster that once raked in billions, has finally lost its patent shield. And when that happens, the copycats flood in with cheaper versions. The money tap isn’t gushing like it used to.
So now, they’re going all in on the next big thing, cell therapy for autoimmune diseases like lupus, arthritis, etc. Capstan isn’t just any random biotech startup. They’re working on a futuristic treatment called CAR-T cell therapy, where doctors train your own immune cells to attack the bad cells in your body, kind of like programming your body’s army with special instructions.
Capstan’s main experimental drug is still in its early stages, but it shows promise for treating autoimmune diseases by targeting and eliminating rogue B-cells (the cells that attack your healthy tissues by mistake).
AbbVie already makes billions from autoimmune drugs like Skyrizi and Rinvoq, but this new tech could push them way ahead of competitors like Vertex, Biogen, and Bristol Myers in the race to dominate the next-gen autoimmune treatment space.
They're not here to play. They're here to dominate the inflammatory space, rewrite the rules, and remind the world they’re not just surviving.
And It's a wrappppp!
What are you waiting for?!?!
Forget not this ministry of yours: Tell a friend to tell a friend to:
Rate us on Playstore or Appstore
Subscribe to our Trove YouTube Channel
Until next time folks!
Catch more gist on our social media pages
Your dearest and favorite Stocks Market Gist Partner,
Tomi, From Trove 💚